Cancer Pain Therapeutics Market Share and Growth 2019: BioDelivery Science, ProStrakan Group, Teva Pharmaceuticals, Eli-Lilly

Logo

Los Angeles, CA -- (SBWire) -- 03/16/2019 --Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.

The global Cancer Pain Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Cancer Pain Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Pain Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/988252/global-cancer-pain-therapeutics-market

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

BioDelivery Science

ProStrakan Group

Teva pharmaceuticals

Eli-Lilly

Grunenthal Group

GW Pharmaceuticals

Johnson?Johnson

Meda Pharmaceuticals

Orexo

Sanofi

WEX Pharmaceuticals

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Opioids

Non-Steroidal Anti-Inflammatory Drugs

Others

Segment by Application

Paracetamol Treatment-Related Immunotherapy

Radiotherapy

Chemotherapy

Hormone Therapy

Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/customize-request/form/988252/global-cancer-pain-therapeutics-market

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, Inc
1-626-295-2442
https://www.qyresearch.com/index/detail/988252/global-cancer-pain-therapeutics-market

View this press release online at: http://rwire.com/1173472